Interaction between arginine vasopressin and angiotensin II receptors in the central regulation of sodium balance


Autoria(s): Saad, W. A.; Camargo, LAD; Antunes-Rodrigues, J.; Guarda, IFMS; Guarda, R. S.
Contribuinte(s)

Universidade Estadual Paulista (UNESP)

Data(s)

20/05/2014

20/05/2014

15/12/2005

Resumo

We speculated that the influence of lateral preoptic area (LPO) in sodium balance, involves arginine(8)-vasopressin (AVP) and angiotensin (ANG II) on Na+ uptake in LPO. Therefore, the present study investigated the effects of central administration of specific AVP and ANG 11 antagonists (d(CH2)(5)-Tyr (Me)-AVP (AAVP) and [Adamanteanacetyl(1), 0-ET-D-Tyr(2), Val(4), Aminobutyryl(6), Arg(8.9)]-AVP (ATAVP) antagonists of V-1 and V-2 receptors of AVP. Also the effects of losartan and CGP42112A (selective ligands of the AT(1) and AT(2) angiotensin receptors, respectively), was investigated on Na+ uptake and renal fluid and electrolyte excretion. After an acclimatization period of 7 days, the animals were maintained under tribromoethanol (200 mg/kg body weight, intraperitonial) anesthesia and placed in a Kopf stereotaxic instrument. Stainless guide cannula was implanted into the LPO. AAVP and ATAVP injected into the LPO prior to AVP produced a reduction in the NaCl intake. Both the AT(1) and AT(2) ligands administered into the LPO elicited a decrease in the NaCl intake induced by AVP injected into the LPO. AVP injection into the LPO increased sodium renal excretion, but this was reduced by prior AAVP administration. The ATAVP produced a decreased in the natriuretic effect of AVP. The losartan injected into LPO previous to AVP decreased the sodium excretion and the CGP 421122A also decreased the natriuretic effect of AVP. The AVP produced an antidiuresis effect that was inhibited by prior administration into LPO of the ATAVP. The AAVP produced no change in the antidiuretic effect of AVP. These results suggest that LPO are implicated in sodium balance that is mediated by V-1, V-2, AT(2) and AT(2) receptors. (c) 2005 Elsevier B.V All rights reserved.

Formato

53-58

Identificador

http://dx.doi.org/10.1016/j.regpep.2005.09.003

Regulatory Peptides. Amsterdam: Elsevier B.V., v. 132, n. 1-3, p. 53-58, 2005.

0167-0115

http://hdl.handle.net/11449/16069

10.1016/j.regpep.2005.09.003

WOS:000233711500009

Idioma(s)

eng

Publicador

Elsevier B.V.

Relação

Regulatory Peptides

Direitos

closedAccess

Palavras-Chave #vasopressin #angiotensin receptor subtypes #sodium balance #lateral preoptic area
Tipo

info:eu-repo/semantics/article